Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by XX% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2023 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by XX% in 2023, of which the U.S. economy will grow by about XX%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2023. However, China's economic growth has slowed down. The 2023 government work report shows that the expected target of economic growth is set at about XX%.
According to research, China has set a growth rate of about XX%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2023, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
VIC Research released the 《Global Organ-On-Chip Market Segment Research Report 2023》, which aims to sort out the development status and trends of the Organ-On-Chip industry at home and abroad, estimate the overall market scale of the Organ-On-Chip industry and the market share of major countries, Organ-On-Chip industry, and study and judge the downstream market demand of Organ-On-Chip through systematic research, Analyze the competition pattern of Organ-On-Chip, so as to help solve the pain points of various stakeholders in Organ-On-Chip industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2019-2028) of Organ-On-Chip Market by VIC Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Organ-On-Chip Market?
Emulate
AxoSim Technologies LLC
CN Bio Innovations
Hurel Corporation
Ascendance Biotechnology
Insphero AG
Mimetas B.V
Nortis Inc
Organovo Holdings
Tara Biosystems
Major Type of Organ-On-Chip Covered in VIC Research report:
Heart-on-chip
Human-on-chip
Intestine-on-chip
Kidney-on-chip
Liver-on-chip
Lung-on-chip
Application Segments Covered in VIC Research Market
Diseases Modelling
Patient Stratification
Phenotypic Screening
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Organ-On-Chip Market Segment Research Report 2023
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Organ-On-Chip Market by Value
2.2.1 Global Organ-On-Chip Revenue by Type
2.2.2 Global Organ-On-Chip Market by Value
2.3 Global Organ-On-Chip Market by Sales
2.3.1 Global Organ-On-Chip Sales by Type
2.3.2 Global Organ-On-Chip Market by Sales
3. The Major Driver of Organ-On-Chip Industry
3.1 Historical & Forecast Global Organ-On-Chip Sales and Revenue (2019-2028)
3.2 Largest Application for Organ-On-Chip (2019-2028)
3.3 The Major Downstream Company in China Market 2023
4. Global and Regional Organ-On-Chip Market
4.1 Regional Market Size in Terms of Sales (2023 & 2028)
4.2 Regional Market Share in Terms of Revenue (2023 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Organ-On-Chip Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Organ-On-Chip Sales (2019-2028)
5.1 Current and Estimated Sales Breakdown by Type (2019-2028)
5.2 Current and Estimated Sales Breakdown by Application (2019-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
6. Europe Organ-On-Chip Sales (2019-2028)
6.1 Current and Estimated Sales Breakdown by Type (2019-2028)
6.2 Current and Estimated Sales Breakdown by Application (2019-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
7. China Organ-On-Chip Sales (2019-2028)
7.1 Current and Estimated Sales Breakdown by Type (2019-2028)
7.2 Current and Estimated Sales Breakdown by Application (2019-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
8. Japan Organ-On-Chip Sales (2019-2028)
8.1 Current and Estimated Sales Breakdown by Type (2019-2028)
8.2 Current and Estimated Sales Breakdown by Application (2019-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
9. India Organ-On-Chip Sales (2019-2028)
9.1 Current and Estimated Sales Breakdown by Type (2019-2028)
9.2 Current and Estimated Sales Breakdown by Application (2019-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
10. Korea Organ-On-Chip Sales (2019-2028)
10.1 Current and Estimated Sales Breakdown by Type (2019-2028)
10.2 Current and Estimated Sales Breakdown by Application (2019-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
11. Southeast Asia Organ-On-Chip Sales (2019-2028)
11.1 Current and Estimated Sales Breakdown by Type (2019-2028)
11.2 Current and Estimated Sales Breakdown by Application (2019-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
12. South America Organ-On-Chip Sales (2019-2028)
12.1 Current and Estimated Sales Breakdown by Type (2019-2028)
12.2 Current and Estimated Sales Breakdown by Application (2019-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2019-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2019-2028)
13. Global Organ-On-Chip Average Price Trend
13.1 Market Price for Each Type of Organ-On-Chip in US (2019-2023)
13.2 Market Price for Each Type of Organ-On-Chip in Europe (2019-2023)
13.3 Market Price for Each Type of Organ-On-Chip in China (2019-2023)
13.4 Market Price for Each Type of Organ-On-Chip in Japan (2019-2023)
13.5 Market Price for Each Type of Organ-On-Chip in India (2019-2023)
13.6 Market Price for Each Type of Organ-On-Chip in Korea (2019-2023)
13.7 Market Price for Each Type of Organ-On-Chip in Southeast Asia (2019-2023)
13.8 Market Price for Each Type of Organ-On-Chip in South America (2019-2023)
14. Industrial Chain (Impact of COVID-19)
14.1 Organ-On-Chip Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Organ-On-Chip
15. Organ-On-Chip Competitive Landscape
15.1 Emulate
15.1.1 Emulate Company Profiles
15.1.2 Emulate Product Introduction
15.1.3 Emulate Organ-On-Chip Sales, Revenue (2019-2023)
15.1.4 Strategic initiatives
15.2 AxoSim Technologies LLC
15.2.1 AxoSim Technologies LLC Company Profiles
15.2.2 AxoSim Technologies LLC Product Introduction
15.2.3 AxoSim Technologies LLC Organ-On-Chip Sales, Revenue (2019-2023)
15.2.4 Strategic initiatives
15.3 CN Bio Innovations
15.3.1 CN Bio Innovations Company Profiles
15.3.2 CN Bio Innovations Product Introduction
15.3.3 CN Bio Innovations Organ-On-Chip Sales, Revenue (2019-2023)
15.3.4 Strategic initiatives
15.4 Hurel Corporation
15.4.1 Hurel Corporation Company Profiles
15.4.2 Hurel Corporation Product Introduction
15.4.3 Hurel Corporation Organ-On-Chip Sales, Revenue (2019-2023)
15.4.4 Strategic initiatives
15.5 Ascendance Biotechnology
15.5.1 Ascendance Biotechnology Company Profiles
15.5.2 Ascendance Biotechnology Product Introduction
15.5.3 Ascendance Biotechnology Organ-On-Chip Sales, Revenue (2019-2023)
15.5.4 Strategic initiatives
15.6 Insphero AG
15.6.1 Insphero AG Company Profiles
15.6.2 Insphero AG Product Introduction
15.6.3 Insphero AG Organ-On-Chip Sales, Revenue (2019-2023)
15.6.4 Strategic initiatives
15.7 Mimetas B.V
15.7.1 Mimetas B.V Company Profiles
15.7.2 Mimetas B.V Product Introduction
15.7.3 Mimetas B.V Organ-On-Chip Sales, Revenue (2019-2023)
15.7.4 Strategic initiatives
15.8 Nortis Inc
15.8.1 Nortis Inc Company Profiles
15.8.2 Nortis Inc Product Introduction
15.8.3 Nortis Inc Organ-On-Chip Sales, Revenue (2019-2023)
15.8.4 Strategic initiatives
15.9 Organovo Holdings
15.9.1 Organovo Holdings Company Profiles
15.9.2 Organovo Holdings Product Introduction
15.9.3 Organovo Holdings Organ-On-Chip Sales, Revenue (2019-2023)
15.9.4 Strategic initiatives
15.10 Tara Biosystems
15.10.1 Tara Biosystems Company Profiles
15.10.2 Tara Biosystems Product Introduction
15.10.3 Tara Biosystems Organ-On-Chip Sales, Revenue (2019-2023)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Organ-On-Chip Industry (Volume)
Figure 2. Organ-On-Chip Sales by Regions in 2023
Figure 3. Regional Market Share in Terms of Revenue (2023&2028)
Figure 4. The Top 10 and 5 Players Market Share by Organ-On-Chip Revenue in 2023
Figure 5. US Organ-On-Chip Sales (2019-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Organ-On-Chip Sales (2019-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Organ-On-Chip Sales (2019-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Organ-On-Chip Sales (2019-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Organ-On-Chip Sales (2019-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Organ-On-Chip Sales (2019-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Organ-On-Chip Sales (2019-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2019-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Organ-On-Chip Revenue, by Type (Million USD) (2019-2028)
Table 4. Organ-On-Chip Sales, by Type (K Unit) (2019-2028)
Table 5. Organ-On-Chip Sales (K Unit) by Application (2019-2028)
Table 6. Organ-On-Chip Sales (Million USD) by Application (2019-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2023)
Table 9. Regional Market Share in Terms of Revenue (2023&2028)
Table 10. Ranking of Global Top Organ-On-Chip Companies by Revenue, Concentration Ratio in 2023
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2019-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Organ-On-Chip Sales (K Unit), Market Revenue (Million USD) (2019-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2019-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2019-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Organ-On-Chip in US (2019-2023)
Table 53. Market Price (USD/Unit) for Each Type of Organ-On-Chip in Europe (2019-2023)
Table 54. Market Price (USD/Unit) for Each Type of Organ-On-Chip in China (2019-2023)
Table 55. Market Price (USD/Unit) for Each Type of Organ-On-Chip in Japan (2019-2023)
Table 56. Market Price (USD/Unit) for Each Type of Organ-On-Chip in India (2019-2023)
Table 57. Market Price (USD/Unit) for Each Type of Organ-On-Chip in Korea (2019-2023)
Table 58. Market Price (USD/Unit) for Each Type of Organ-On-Chip in Southeast Asia (2019-2023)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Emulate Profiles
Table 61. Emulate Organ-On-Chip Product Introduction
Table 62. Emulate Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 63. Emulate Strategic initiatives
Table 64. AxoSim Technologies LLC Profiles
Table 65. AxoSim Technologies LLC Organ-On-Chip Product Introduction
Table 66. AxoSim Technologies LLC Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 67. AxoSim Technologies LLC Strategic initiatives
Table 68. CN Bio Innovations Profiles
Table 69. CN Bio Innovations Organ-On-Chip Product Introduction
Table 70. CN Bio Innovations Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 71. CN Bio Innovations Strategic initiatives
Table 72. Hurel Corporation Profiles
Table 73. Hurel Corporation Organ-On-Chip Product Introduction
Table 74. Hurel Corporation Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 75. Hurel Corporation Strategic initiatives
Table 76. Ascendance Biotechnology Profiles
Table 77. Ascendance Biotechnology Organ-On-Chip Product Introduction
Table 78. Ascendance Biotechnology Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 79. Ascendance Biotechnology Strategic initiatives
Table 80. Insphero AG Profiles
Table 81. Insphero AG Organ-On-Chip Product Introduction
Table 82. Insphero AG Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 83. Insphero AG Strategic initiatives
Table 84. Mimetas B.V Profiles
Table 85. Mimetas B.V Organ-On-Chip Product Introduction
Table 86. Mimetas B.V Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 87. Mimetas B.V Strategic initiatives
Table 88. Nortis Inc Profiles
Table 89. Nortis Inc Organ-On-Chip Product Introduction
Table 90. Nortis Inc Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 91. Nortis Inc Strategic initiatives
Table 92. Organovo Holdings Profiles
Table 93. Organovo Holdings Organ-On-Chip Product Introduction
Table 94. Organovo Holdings Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 95. Organovo Holdings Strategic initiatives
Table 97. Tara Biosystems Profiles
Table 98. Tara Biosystems Organ-On-Chip Product Introduction
Table 99. Tara Biosystems Organ-On-Chip Sales (Unit), Revenue (Million USD) (2019-2023)
Table 100. Tara Biosystems Strategic initiatives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
